Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles

Journal of Virology

Volumn 71, Issue 6, 1997, Pages 4832-4837

  Cartier, Christine ^a   Deckert, Marcel ^a,d   Grangeasse, Christophe ^b   Trauger, Richard ^c   Jensen, Fred ^c   Bernard, Alain ^a   Cozzone, Alain ^b   Desgranges, Claude ^a   Boyer, Veronique ^a  

^a INSERM   (France)

^b INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^c Orchestra Therapeutics Inc   (United States)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GAG PROTEIN; HISTONE; MITOGEN ACTIVATED PROTEIN KINASE;

AMINO ACID ANALYSIS; ARTICLE; AUTOPHOSPHORYLATION; CELL LINE; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VIRUS PARTICLE; VIRUS PURIFICATION;

EID: 0030958825     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.6.4832-4837.1997     Document Type: Article

References (34)

1. Alexander, D. R., and D. A. Cantrell. 1989. Kinases and phosphatases in T-cell activation. Immunol. Today 10:200-205.
2. Arthur, L. O., J. W. Bess, R. C. Sowder, R. E. Benveniste, D. L. Mann, J.-C. Chermann, and L. E. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258:1935-1938.
3. Braaten, D., E. K. Franke, and J. Luban. 1996. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70:3551-3560.
4. Bukrinskaya, A. G., A. Ghorpade, N. K. Heinzinger, T. E. Smithgall, R. E. Lewis, and M. Stevenson. 1996. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA 93:367-371.
5. Chen, D., S. B. Waters, K. H. Holt, and J. E. Pessin. 1996. SOS phosphorylation and disassociation of the Grb2-SOS complex by the ERK and JNK signaling pathways. J. Biol. Chem. 271:6328-6332.
6. Cohen, D. I., Y. Tani, H. Tian, E. Boone, L. E. Samelson, and H. C. Lane. 1992. Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1. Science 256:542-545.
7. Davis, R. J. 1993. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:14553-14556.
8. Desai, S. M., V. S. Kalyanaraman, J. M. Casey, A. Srinivasan, P. R. Andersen, and S. G. Devare. 1986. Molecular cloning and primary nucleotide sequence analysis of a distinct human immunodeficiency virus isolate reveal significant divergence in its genomic sequences. Proc. Natl. Acad. Sci. USA 83:8380-8384.
9. Duclos, B., S. Marcandier, and A. J. Cozzone. 1991. Chemical properties and separation of phosphoamino acids by thin-layer chromatography and/or electrophoresis. Methods Enzymol. 201:10-21.
10. Fields, A. P., D. P. Bednarik, A. Hess, and W. S. May. 1988. Human immunodeficiency virus induces phosphorylation of its cell surface receptor. Nature 333:278-280.
11. Folgueira, L., J. A. McElhinny, G. D. Bren, W. S. MacMorran, M. T. Diaz-Meco, J. Moscat, and C. V. Paya. 1996. Protein kinase C-ζ mediates NF-κB activation in human immunodeficiency virus-infected monocytes. J. Virol. 70:223-231.
12. Franke, E. K., H. E. H. Yuan, and J. Luban. 1994. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359-362.
13. Gallay, P., S. Swingler, C. Aiken, and D. Trono. 1995. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80:379-388.
14. Gallay, P., S. Swingler, J. Song, F. Bushman, and D. Trono. 1995. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83:569-576.
15. Garrett, E. D., L. S. Tiley, and B. R. Cullen. 1991. Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products. J. Virol. 65:1653-1657.
16. Grandgenett, D. P., and G. Goodarzi. 1994. Folding of the multidomain human immunodeficiency virus type-I integrase. Prot. Sci. 3:888-897.
17. Hatanaka, M., E. Twiddy, and R. V. Gilden. 1972. Protein kinase associated with RNA tumour viruses and other budding RNA viruses. Virology 47:536-538.
18. Huet, T., M. C. Dazza, F. Brun-Vezinet, G. E. Roelants, and S. Wain-Hobson. 1989. A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical Western blot. AIDS 3:707-715.
19. Kameshita, I., and H. Fujisawa. 1989. A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal. Biochem. 183:139-143.
20. Kann, M., and W. H. Gerlich. 1994. Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus. J. Virol. 68:7993-8000.
21. Lee, S. W., C. Tomasetto, and R. Sager. 1991. Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc. Natl. Acad. Sci. USA 88:2825-2829.
22. Lee Guo, M. M., and J. E. K. Hildreth. 1995. HIV acquires functional adhesion receptors from host cells. AIDS Res. Hum. Retroviruses 11:1007-1013.
23. Luban, J., K. A. Bossolt, E. K. Franke, G. V. Kalpana, and S. P. Goff. 1993. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73:1067-1078.
24. Marshall, C. J. 1994. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 4:82-89.
25. Meerloo, T., M. A. Sheikh, A. C. Bloem, A. de Ronde, M. Scutten, C. A. C. van Els, P. J. M. Roholl, P. Joling, J. Goodsmit, and H.-J. Schuurman. 1993. Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immunoelectron microscopic study. J. Gen. Virol. 74:129-135.
26. Paoletti, E., and B. Moss. 1972. Protein kinase and specific phosphate acceptor proteins associated with vaccinia virus cores. J. Virol. 10:417-424.
27. Prior, C., P. Bay, B. Ebert, R. Gore, J. Holt, T. Irish, F. Jensen, C. Leone, J. Mitschelen, M. Stiglitz, C. Tarr, R. J. Trauger, D. Weber, and M. Hrinda. 1995. Process development for the manufacture of inactivated HIV-1. Pharm. Technol. 5:30-52.
28. Randall, C. C., H. W. Rogers, D. N. Downer, and G. A. Gentry. 1972. Protein kinase activity in equine herpesvirus. J. Virol. 9:216-222.
29. Roby, C., and W. Gibson. 1986. Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus. J. Virol. 59:714-727.
30. Seger, R., and E. G. Krebs. 1995. The MAPK signaling cascade. FASEB J. 9:726-735.
31. Stevenson, M. 1996. Portals of entry: uncovering HIV nuclear transport pathways. Trends Cell Biol. 6:9-15.
32. Strand, M., and J. T. August. 1971. Protein kinase and phosphate acceptor proteins in Rauscher murine leukemia virus. Nature New Biol. 233:137-140.
33. Thall, M., A. Bukovsky, E. Kondo, B. Rosenwirth, C. T. Walsh, J. Sodroski, and H. G. Göttlinger. 1994. Functional association of cyclophilin A with HIV-1 virions. Nature 372:363-365.
34. Trauger, R., F. Ferre, A. Daigle, S. Richieri, F. Jensen, and D. Carlo. 1994. The effect of immunization with an inactivated envelope-depleted human immunodeficiency virus type 1 (HIV-1) immunogen in incomplete Freund's adjuvant (IFA) on HIV-1 immunity, viral DNA, and percent of CD4 cells. J. Infect. Dis. 169:1256-1264.